Endometrial cancer: predictors and oncological safety of tumor tissue manipulation

Purpose The main goal of this study is to assess the impact of tumor manipulation on the presence of lympho-vascular space invasion and its influence on oncological results. Methods We performed a retrospective multi-centric study amongst patients who had received primary surgical treatment for appa...

Full description

Saved in:
Bibliographic Details
Published inClinical & translational oncology Vol. 26; no. 5; pp. 1098 - 1105
Main Authors Quintana-Bertó, Raquel, Padilla-Iserte, Pablo, Lago, Víctor, Tauste, Carmen, Díaz-Feijoo, Berta, Cabrera, Silvia, Oliver-Pérez, Reyes, Coronado, Pluvio J., Martín-Salamanca, María Belén, Pantoja-Garrido, Manuel, Marcos-Sanmartin, Josefa, Cazorla, Eduardo, Lorenzo, Cristina, Rodríguez-Hernández, José Ramón, Roldán-Rivas, Fernando, Gilabert-Estellés, Juan, Muruzábal, Juan Carlos, Cañada, Antonio, Domingo, Santiago
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.05.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose The main goal of this study is to assess the impact of tumor manipulation on the presence of lympho-vascular space invasion and its influence on oncological results. Methods We performed a retrospective multi-centric study amongst patients who had received primary surgical treatment for apparently early-stage endometrial cancer. A multivariate statistical analysis model was designed to assess the impact that tumor manipulation (with the use of uterine manipulator or preoperative hysteroscopy) has on lympho-vascular development (LVSI) in the final surgical specimen. Results A total of 2852 women from 15 centers were included and divided into two groups based on the lympho-vascular status in the final surgical specimen: 2265 (79.4%) had no LVSI and 587 (20.6%) presented LVSI. The use of uterine manipulator was associated with higher chances of lympho-vascular involvement regardless of the type used: Balloon manipulator (HR: 95% CI 4.64 (2.99–7.33); p  < 0.001) and No-Balloon manipulator ([HR]: 95% CI 2.54 (1.66–3.96); p  < 0.001). There is no evidence of an association between the use of preoperative hysteroscopy and higher chances of lympho-vascular involvement (HR: 95% CI 0.90 (0.68–1.19); p  = 0.479). Conclusion Whilst performing common gynecological procedures, iatrogenic distention and manipulation of the uterine cavity are produced. Our study suggests that the use of uterine manipulator increases the rate of LVSI and, therefore, leads to poorer oncological results. Conversely, preoperative hysteroscopy does not show higher rates of LVSI involvement in the final surgical specimen and can be safely used.
AbstractList Purpose The main goal of this study is to assess the impact of tumor manipulation on the presence of lympho-vascular space invasion and its influence on oncological results. Methods We performed a retrospective multi-centric study amongst patients who had received primary surgical treatment for apparently early-stage endometrial cancer. A multivariate statistical analysis model was designed to assess the impact that tumor manipulation (with the use of uterine manipulator or preoperative hysteroscopy) has on lympho-vascular development (LVSI) in the final surgical specimen. Results A total of 2852 women from 15 centers were included and divided into two groups based on the lympho-vascular status in the final surgical specimen: 2265 (79.4%) had no LVSI and 587 (20.6%) presented LVSI. The use of uterine manipulator was associated with higher chances of lympho-vascular involvement regardless of the type used: Balloon manipulator (HR: 95% CI 4.64 (2.99–7.33); p  < 0.001) and No-Balloon manipulator ([HR]: 95% CI 2.54 (1.66–3.96); p  < 0.001). There is no evidence of an association between the use of preoperative hysteroscopy and higher chances of lympho-vascular involvement (HR: 95% CI 0.90 (0.68–1.19); p  = 0.479). Conclusion Whilst performing common gynecological procedures, iatrogenic distention and manipulation of the uterine cavity are produced. Our study suggests that the use of uterine manipulator increases the rate of LVSI and, therefore, leads to poorer oncological results. Conversely, preoperative hysteroscopy does not show higher rates of LVSI involvement in the final surgical specimen and can be safely used.
The main goal of this study is to assess the impact of tumor manipulation on the presence of lympho-vascular space invasion and its influence on oncological results. We performed a retrospective multi-centric study amongst patients who had received primary surgical treatment for apparently early-stage endometrial cancer. A multivariate statistical analysis model was designed to assess the impact that tumor manipulation (with the use of uterine manipulator or preoperative hysteroscopy) has on lympho-vascular development (LVSI) in the final surgical specimen. A total of 2852 women from 15 centers were included and divided into two groups based on the lympho-vascular status in the final surgical specimen: 2265 (79.4%) had no LVSI and 587 (20.6%) presented LVSI. The use of uterine manipulator was associated with higher chances of lympho-vascular involvement regardless of the type used: Balloon manipulator (HR: 95% CI 4.64 (2.99-7.33); p < 0.001) and No-Balloon manipulator ([HR]: 95% CI 2.54 (1.66-3.96); p < 0.001). There is no evidence of an association between the use of preoperative hysteroscopy and higher chances of lympho-vascular involvement (HR: 95% CI 0.90 (0.68-1.19); p = 0.479). Whilst performing common gynecological procedures, iatrogenic distention and manipulation of the uterine cavity are produced. Our study suggests that the use of uterine manipulator increases the rate of LVSI and, therefore, leads to poorer oncological results. Conversely, preoperative hysteroscopy does not show higher rates of LVSI involvement in the final surgical specimen and can be safely used.
The main goal of this study is to assess the impact of tumor manipulation on the presence of lympho-vascular space invasion and its influence on oncological results.PURPOSEThe main goal of this study is to assess the impact of tumor manipulation on the presence of lympho-vascular space invasion and its influence on oncological results.We performed a retrospective multi-centric study amongst patients who had received primary surgical treatment for apparently early-stage endometrial cancer. A multivariate statistical analysis model was designed to assess the impact that tumor manipulation (with the use of uterine manipulator or preoperative hysteroscopy) has on lympho-vascular development (LVSI) in the final surgical specimen.METHODSWe performed a retrospective multi-centric study amongst patients who had received primary surgical treatment for apparently early-stage endometrial cancer. A multivariate statistical analysis model was designed to assess the impact that tumor manipulation (with the use of uterine manipulator or preoperative hysteroscopy) has on lympho-vascular development (LVSI) in the final surgical specimen.A total of 2852 women from 15 centers were included and divided into two groups based on the lympho-vascular status in the final surgical specimen: 2265 (79.4%) had no LVSI and 587 (20.6%) presented LVSI. The use of uterine manipulator was associated with higher chances of lympho-vascular involvement regardless of the type used: Balloon manipulator (HR: 95% CI 4.64 (2.99-7.33); p < 0.001) and No-Balloon manipulator ([HR]: 95% CI 2.54 (1.66-3.96); p < 0.001). There is no evidence of an association between the use of preoperative hysteroscopy and higher chances of lympho-vascular involvement (HR: 95% CI 0.90 (0.68-1.19); p = 0.479).RESULTSA total of 2852 women from 15 centers were included and divided into two groups based on the lympho-vascular status in the final surgical specimen: 2265 (79.4%) had no LVSI and 587 (20.6%) presented LVSI. The use of uterine manipulator was associated with higher chances of lympho-vascular involvement regardless of the type used: Balloon manipulator (HR: 95% CI 4.64 (2.99-7.33); p < 0.001) and No-Balloon manipulator ([HR]: 95% CI 2.54 (1.66-3.96); p < 0.001). There is no evidence of an association between the use of preoperative hysteroscopy and higher chances of lympho-vascular involvement (HR: 95% CI 0.90 (0.68-1.19); p = 0.479).Whilst performing common gynecological procedures, iatrogenic distention and manipulation of the uterine cavity are produced. Our study suggests that the use of uterine manipulator increases the rate of LVSI and, therefore, leads to poorer oncological results. Conversely, preoperative hysteroscopy does not show higher rates of LVSI involvement in the final surgical specimen and can be safely used.CONCLUSIONWhilst performing common gynecological procedures, iatrogenic distention and manipulation of the uterine cavity are produced. Our study suggests that the use of uterine manipulator increases the rate of LVSI and, therefore, leads to poorer oncological results. Conversely, preoperative hysteroscopy does not show higher rates of LVSI involvement in the final surgical specimen and can be safely used.
Author Marcos-Sanmartin, Josefa
Quintana-Bertó, Raquel
Pantoja-Garrido, Manuel
Martín-Salamanca, María Belén
Tauste, Carmen
Rodríguez-Hernández, José Ramón
Lago, Víctor
Domingo, Santiago
Roldán-Rivas, Fernando
Coronado, Pluvio J.
Muruzábal, Juan Carlos
Gilabert-Estellés, Juan
Oliver-Pérez, Reyes
Padilla-Iserte, Pablo
Cazorla, Eduardo
Cabrera, Silvia
Lorenzo, Cristina
Díaz-Feijoo, Berta
Cañada, Antonio
Author_xml – sequence: 1
  givenname: Raquel
  orcidid: 0000-0001-5239-3756
  surname: Quintana-Bertó
  fullname: Quintana-Bertó, Raquel
  email: raquelqb.25@gmail.com
  organization: Department of Gynecologic Oncology, La Fe University and Polytechnic Hospital
– sequence: 2
  givenname: Pablo
  surname: Padilla-Iserte
  fullname: Padilla-Iserte, Pablo
  organization: Department of Gynecologic Oncology, La Fe University and Polytechnic Hospital
– sequence: 3
  givenname: Víctor
  surname: Lago
  fullname: Lago, Víctor
  organization: Department of Gynecologic Oncology, La Fe University and Polytechnic Hospital
– sequence: 4
  givenname: Carmen
  surname: Tauste
  fullname: Tauste, Carmen
  organization: Department of Gynecologic Oncology, Complejo Hospitalario de Navarra
– sequence: 5
  givenname: Berta
  surname: Díaz-Feijoo
  fullname: Díaz-Feijoo, Berta
  organization: Institute Clinic of Gynecology, Obstetrics and Neonatology, Hospital Clinic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona
– sequence: 6
  givenname: Silvia
  surname: Cabrera
  fullname: Cabrera, Silvia
  organization: Gynecologic Oncology Unit, Gynecology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona
– sequence: 7
  givenname: Reyes
  surname: Oliver-Pérez
  fullname: Oliver-Pérez, Reyes
  organization: Gynecologic Oncology-Unit, Department of Obstetrics and Gynecology, University Hospital 12 de Octubre, 12 de Octubre Research Institute, Complutense University of Madrid
– sequence: 8
  givenname: Pluvio J.
  surname: Coronado
  fullname: Coronado, Pluvio J.
  organization: Women’s Health Institute of the Hospital Clínico San Carlos, IdISSC, University Complutense
– sequence: 9
  givenname: María Belén
  surname: Martín-Salamanca
  fullname: Martín-Salamanca, María Belén
  organization: Gynecology Department, Hospital Universitario de Getafe
– sequence: 10
  givenname: Manuel
  surname: Pantoja-Garrido
  fullname: Pantoja-Garrido, Manuel
  organization: Department of Gynecology and Obstetrics, University Hospital Virgen Macarena
– sequence: 11
  givenname: Josefa
  surname: Marcos-Sanmartin
  fullname: Marcos-Sanmartin, Josefa
  organization: Department of Obstetrics and Gynecology, Dr. Balmis General University Hospital, Department of Public Health, Miguel Hernández University, Sant Joan d‘Alacant, Institute for Health and Biomedical Research (ISABIAL)
– sequence: 12
  givenname: Eduardo
  surname: Cazorla
  fullname: Cazorla, Eduardo
  organization: Department of Obstetrics and Gynecology, Hospital Universitario de Torrevieja
– sequence: 13
  givenname: Cristina
  surname: Lorenzo
  fullname: Lorenzo, Cristina
  organization: Department of Obstetrics and Gynecology, Hospital Nuestra Señora de La Calendaria
– sequence: 14
  givenname: José Ramón
  surname: Rodríguez-Hernández
  fullname: Rodríguez-Hernández, José Ramón
  organization: Gynaecology and Obstetrics Department, University Hospital Virgen de La Arrixaca
– sequence: 15
  givenname: Fernando
  surname: Roldán-Rivas
  fullname: Roldán-Rivas, Fernando
  organization: Department of Obstetrics and Gynaecology, Clinico Lozano Blesa Hospital
– sequence: 16
  givenname: Juan
  surname: Gilabert-Estellés
  fullname: Gilabert-Estellés, Juan
  organization: Department of Obstetrics and Gynecology, University General Hospital of València
– sequence: 17
  givenname: Juan Carlos
  surname: Muruzábal
  fullname: Muruzábal, Juan Carlos
  organization: Department of Gynecologic Oncology, Complejo Hospitalario de Navarra
– sequence: 18
  givenname: Antonio
  surname: Cañada
  fullname: Cañada, Antonio
  organization: Department of Biostatistics, Health Research Institute La Fe
– sequence: 19
  givenname: Santiago
  surname: Domingo
  fullname: Domingo, Santiago
  organization: Department of Gynecologic Oncology, La Fe University and Polytechnic Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37668932$$D View this record in MEDLINE/PubMed
BookMark eNp9kMtKxDAUhoOMOBd9AReSpZtqbk0bdzKMFxgQRNchTdMhQ5vUJF3M29uxKq5cnQPn-3843xLMnHcGgEuMbjBCxW3EBAmWIUIzRClGGT8BC8yFyCjK89mffQ6WMe7RuHGMz8CcFpyXgpIFeN242ncmBataqJXTJtzBPpja6uRDhMrV0DvtW7-zekSiakw6QN_ANHQ-wGRjHAzslLP90KpkvTsHp41qo7n4nivw_rB5Wz9l25fH5_X9NtNElCkrGkGZIpgWDWs0oznJecFzZjjTtdYNUkxgyouKlbrUtVBVTVBF87LIx2cpoStwPfX2wX8MJibZ2ahN2ypn_BAlKTmmiHHOR5RMqA4-xmAa2QfbqXCQGMmjSzm5lKNL-eVSHkNX3_1D1Zn6N_IjbwToBMTx5HYmyL0fght__q_2E7ZZgQU
Cites_doi 10.1016/j.ijgo.2009.02.012
10.1097/IGC.0000000000001181
10.1097/PAS.0b013e31816098f0
10.3322/caac.21763
10.1016/j.ajog.2020.07.025
10.18637/jss.v033.i01
10.21037/tcr-20-2094
10.1007/s00404-015-3727-9
10.18637/jss.v039.i05
10.1136/ijgc-2022-003586
10.1016/j.ejca.2015.05.015
10.1097/PAS.0b013e31818a01bf
10.1016/j.ygyno.2007.05.031
10.4293/JSLS.2019.00021
10.1097/gme.0b013e3181c8534d
10.1016/j.ejogrb.2019.10.042
10.1016/j.ijgo.2009.02.008
10.3322/caac.21660
10.1111/ajo.12089
10.1007/978-1-4757-3294-8
10.1097/PAS.0b013e31820273dc
10.4132/KoreanJPathol.2013.47.4.355
10.1097/IGC.0000000000001022
10.1016/j.ejogrb.2019.12.020
10.1016/j.ejogrb.2004.01.029
10.1136/ijgc-2020-002230
10.1016/j.ygyno.2016.01.002
10.1016/S0140-6736(08)60269-X
10.5040/9781782258674
10.1007/s13304-019-00681-w
10.1016/j.fertnstert.2011.07.1146
10.1097/PGP.0000000000000496
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2023. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
Copyright_xml – notice: The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2023. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
CorporateAuthor SEGO Spain-GOG Group
CorporateAuthor_xml – name: SEGO Spain-GOG Group
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1007/s12094-023-03310-6
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1699-3055
EndPage 1105
ExternalDocumentID 10_1007_s12094_023_03310_6
37668932
Genre Journal Article
GroupedDBID -05
-0E
-5E
-5G
-BR
-EM
-S~
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
203
29B
29~
2B.
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
4.4
406
408
40D
40E
53G
5GY
5VR
5VS
67Z
6NX
8TC
8UJ
92I
92M
93N
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAFGU
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
ABAKF
ABDZT
ABECU
ABFGW
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACBMV
ACBRV
ACBYP
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACTTH
ACVWB
ACWMK
ACZOJ
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFBBN
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
AXYYD
B-.
BA0
BDATZ
BGNMA
CAG
CCEZO
CHBEP
CIEJG
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
EBLON
EBS
EIOEI
EJD
EN4
ESBYG
F5P
FA0
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
HF~
HG5
HG6
HMJXF
HRMNR
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXD
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JUIAU
JZLTJ
KOV
KPH
LLZTM
M4Y
MA-
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
P2P
P9S
PF0
PT4
Q--
Q-4
QOR
QOS
R89
R9I
ROL
RPX
RSV
RT5
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
SZN
T13
T8U
TCJ
TEORI
TSG
TSK
TSV
TT1
TUC
U1F
U1G
U2A
U5O
U9L
UG4
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
YLTOR
Z45
Z7D
Z7U
Z82
Z87
ZMTXR
ZOVNA
~A9
~N8
AAYZH
H13
NPM
SJYHP
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c298t-7f934a2137f4fc4352567654e64cdccf0a491367b48c8cd9abd20b35875331323
IEDL.DBID AGYKE
ISSN 1699-3055
IngestDate Sat Oct 26 04:52:12 EDT 2024
Thu Sep 12 16:36:45 EDT 2024
Sat Nov 02 12:29:55 EDT 2024
Fri Apr 19 01:11:20 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Hysteroscopy
Oncological outcomes
Endometrial cancer
Uterine manipulator
Language English
License 2023. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c298t-7f934a2137f4fc4352567654e64cdccf0a491367b48c8cd9abd20b35875331323
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-5239-3756
PMID 37668932
PQID 2861304666
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2861304666
crossref_primary_10_1007_s12094_023_03310_6
pubmed_primary_37668932
springer_journals_10_1007_s12094_023_03310_6
PublicationCentury 2000
PublicationDate 2024-05-01
PublicationDateYYYYMMDD 2024-05-01
PublicationDate_xml – month: 05
  year: 2024
  text: 2024-05-01
  day: 01
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: Italy
PublicationTitle Clinical & translational oncology
PublicationTitleAbbrev Clin Transl Oncol
PublicationTitleAlternate Clin Transl Oncol
PublicationYear 2024
Publisher Springer International Publishing
Publisher_xml – name: Springer International Publishing
References Kim, Park, Jung, Lee, Min, Kim (CR14) 2013; 47
Therneau, Grambsch (CR19) 2000
Namazov, Gemer, Helpman, Hag-Yahia, Eitan, Raban (CR33) 2019; 243
Sung, Ferlay, Siegel, Laversanne, Soerjomataram, Jemal (CR2) 2021; 71
Logani, Herdman, Little, Moller (CR10) 2008; 32
Krizova, Clarke, Bernardini, James, Kalloger, Boerner (CR25) 2011; 35
CR17
Pecorelli (CR15) 2009; 105
Padilla-Iserte, Lago, Tauste, Díaz-Feijoo, Gil-Moreno, Oliver (CR9) 2021; 224
Hahn, Lee, Kim, Lee, Shim, Kim (CR7) 2013; 53
Gueli Alletti, Perrone, Cretì, Cianci, Uccella, Fedele (CR22) 2020; 245
Renehan, Tyson, Egger, Heller, Zwahlen (CR3) 2008; 371
Radley-Gardner, Beale, Zimmermann (CR13) 2016
Capozzi, Rosati, Uccella, Riemma, Tarascio, Torella (CR21) 2020; 9
Machida, Hom, Adams, Eckhardt, Garcia-Sayre, Mikami (CR27) 2018; 28
Bosse, Peters, Creutzberg, Jürgenliemk-Schulz, Jobsen, Mens (CR8) 2015; 51
Concin, Matias-Guiu, Vergote, Cibula, Mirza, Marnitz (CR4) 2021; 31
Friedman, Hastie, Tibshirani (CR16) 2010; 33
Jorge, Hou, Tergas, Burke, Huang, Hu (CR6) 2016; 140
Abdel Khalek, Bitar, Christoforou, Garzon, Tropea, Biondi (CR24) 2020; 72
Simon, Friedman, Hastie, Tibshirani (CR18) 2011; 39
Siegel, Miller, Wagle, Jemal (CR1) 2023; 73
Chang, Zhang, Wang, Wang, Duan (CR34) 2011; 96
Dewdney, Jiao, Roma, Gao, Rimel, Thaker (CR12) 2014; 35
Gorostidi Pulgar, Diaz de la Noval, Gil-Ibañez, Lago Leal, Jaunarena Marin, Padilla (CR20) 2017; 27
Seifi, Parkash, Clark, Menderes, Tierney, Silasi (CR28) 2019; 23
Cho, Cooper, Croce, Djordevic, Herrington, Howitt (CR5) 2019; 38
Kitahara, Walsh, Frumovitz, Malpica, Silva (CR26) 2009; 33
van den Haak, Alleblas, Nieboer, Rhemrev, Jansen (CR23) 2015; 292
Quintana-Bertó, Padilla-Iserte, Gil-Moreno, Oliver-Pérez, Coronado, Martín-Salamanca (CR31) 2022
Sáinz de la Cuesta, Espinosa, Crespo, Granizo, Rivas (CR30) 2004; 115
Takac, Zegura (CR11) 2007; 107
Cicinelli, Tinelli, Colafiglio, Fortunato, Fusco, Mastrolia (CR32) 2010; 17
Mariani, Dowdy, Podratz (CR29) 2009; 105
S Kim (3310_CR14) 2013; 47
Y Abdel Khalek (3310_CR24) 2020; 72
F Seifi (3310_CR28) 2019; 23
3310_CR17
AG Renehan (3310_CR3) 2008; 371
P Padilla-Iserte (3310_CR9) 2021; 224
YN Chang (3310_CR34) 2011; 96
J Friedman (3310_CR16) 2010; 33
A Krizova (3310_CR25) 2011; 35
R Sáinz de la Cuesta (3310_CR30) 2004; 115
I Takac (3310_CR11) 2007; 107
VA Capozzi (3310_CR21) 2020; 9
KR Cho (3310_CR5) 2019; 38
L van den Haak (3310_CR23) 2015; 292
H Sung (3310_CR2) 2021; 71
A Namazov (3310_CR33) 2019; 243
HS Hahn (3310_CR7) 2013; 53
TM Therneau (3310_CR19) 2000
A Mariani (3310_CR29) 2009; 105
SB Dewdney (3310_CR12) 2014; 35
E Cicinelli (3310_CR32) 2010; 17
O Radley-Gardner (3310_CR13) 2016
S Kitahara (3310_CR26) 2009; 33
S Logani (3310_CR10) 2008; 32
S Jorge (3310_CR6) 2016; 140
N Concin (3310_CR4) 2021; 31
N Simon (3310_CR18) 2011; 39
S Pecorelli (3310_CR15) 2009; 105
R Quintana-Bertó (3310_CR31) 2022
H Machida (3310_CR27) 2018; 28
RL Siegel (3310_CR1) 2023; 73
M Gorostidi Pulgar (3310_CR20) 2017; 27
S Gueli Alletti (3310_CR22) 2020; 245
T Bosse (3310_CR8) 2015; 51
References_xml – volume: 105
  start-page: 103
  issue: 2
  year: 2009
  end-page: 104
  ident: CR15
  article-title: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
  publication-title: Int J Gynaecol Obstet
  doi: 10.1016/j.ijgo.2009.02.012
  contributor:
    fullname: Pecorelli
– volume: 28
  start-page: 208
  issue: 2
  year: 2018
  end-page: 219
  ident: CR27
  article-title: Intrauterine manipulator use during minimally invasive hysterectomy and risk of lymphovascular space invasion in endometrial cancer
  publication-title: Int J Gynecol Cancer
  doi: 10.1097/IGC.0000000000001181
  contributor:
    fullname: Mikami
– volume: 35
  start-page: 7
  issue: 1
  year: 2014
  end-page: 10
  ident: CR12
  article-title: The prognostic significance of lymphovascular space invasion in laparoscopic versus abdominal hysterectomy for endometrioid endometrial cancer
  publication-title: Eur J Gynaecol Oncol
  contributor:
    fullname: Thaker
– volume: 32
  start-page: 560
  issue: 4
  year: 2008
  end-page: 565
  ident: CR10
  article-title: Vascular “pseudo invasion” in laparoscopic hysterectomy specimens: a diagnostic pitfall
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e31816098f0
  contributor:
    fullname: Moller
– volume: 73
  start-page: 17
  issue: 1
  year: 2023
  end-page: 48
  ident: CR1
  article-title: Cancer statistics, 2023
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21763
  contributor:
    fullname: Jemal
– volume: 224
  start-page: 65.e1
  issue: 1
  year: 2021
  end-page: 65.e11
  ident: CR9
  article-title: Impact of uterine manipulator on oncological outcome in endometrial cancer surgery
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2020.07.025
  contributor:
    fullname: Oliver
– volume: 33
  start-page: 1
  issue: 1
  year: 2010
  end-page: 22
  ident: CR16
  article-title: Regularization paths for generalized linear models via coordinate descent
  publication-title: J Stat Softw
  doi: 10.18637/jss.v033.i01
  contributor:
    fullname: Tibshirani
– volume: 9
  start-page: 7759
  issue: 12
  year: 2020
  end-page: 7766
  ident: CR21
  article-title: Role of uterine manipulator during laparoscopic endometrial cancer treatment
  publication-title: Transl Cancer Res
  doi: 10.21037/tcr-20-2094
  contributor:
    fullname: Torella
– volume: 292
  start-page: 1003
  issue: 5
  year: 2015
  end-page: 1011
  ident: CR23
  article-title: Efficacy and safety of uterine manipulators in laparoscopic surgery: a review
  publication-title: Arch Gynecol Obstet
  doi: 10.1007/s00404-015-3727-9
  contributor:
    fullname: Jansen
– volume: 39
  start-page: 1
  issue: 5
  year: 2011
  ident: CR18
  article-title: Regularization paths for cox’s proportional hazards model via coordinate descent
  publication-title: J Stat Softw
  doi: 10.18637/jss.v039.i05
  contributor:
    fullname: Tibshirani
– year: 2022
  ident: CR31
  article-title: Oncological safety of hysteroscopy in endometrial cancer
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2022-003586
  contributor:
    fullname: Martín-Salamanca
– volume: 51
  start-page: 1742
  issue: 13
  year: 2015
  end-page: 1750
  ident: CR8
  article-title: Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer—a pooled analysis of PORTEC 1 and 2 trials
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2015.05.015
  contributor:
    fullname: Mens
– volume: 33
  start-page: 298
  issue: 2
  year: 2009
  end-page: 303
  ident: CR26
  article-title: Vascular pseudoinvasion in laparoscopic hysterectomy specimens for endometrial carcinoma: a grossing artifact?
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e31818a01bf
  contributor:
    fullname: Silva
– volume: 107
  start-page: 94
  issue: 1
  year: 2007
  end-page: 98
  ident: CR11
  article-title: Office hysteroscopy and the risk of microscopic extrauterine spread in endometrial cancer
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2007.05.031
  contributor:
    fullname: Zegura
– volume: 23
  start-page: e2019.00021
  issue: 2
  year: 2019
  ident: CR28
  article-title: Pseudovascular invasion: minimally invasive surgery for endometrial cancer
  publication-title: JSLS
  doi: 10.4293/JSLS.2019.00021
  contributor:
    fullname: Silasi
– volume: 17
  start-page: 511
  issue: 3
  year: 2010
  end-page: 515
  ident: CR32
  article-title: Risk of long-term pelvic recurrences after fluid minihysteroscopy in women with endometrial carcinoma: a controlled randomized study
  publication-title: Menopause N Y N
  doi: 10.1097/gme.0b013e3181c8534d
  contributor:
    fullname: Mastrolia
– volume: 243
  start-page: 120
  year: 2019
  end-page: 124
  ident: CR33
  article-title: The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: an Israel gynecologic oncology group study
  publication-title: Eur J Obstet Gynecol Reprod Biol
  doi: 10.1016/j.ejogrb.2019.10.042
  contributor:
    fullname: Raban
– volume: 105
  start-page: 110
  issue: 2
  year: 2009
  end-page: 111
  ident: CR29
  article-title: New surgical staging of endometrial cancer: 20 years later
  publication-title: Int J Gynecol Obstet
  doi: 10.1016/j.ijgo.2009.02.008
  contributor:
    fullname: Podratz
– volume: 71
  start-page: 209
  issue: 3
  year: 2021
  end-page: 249
  ident: CR2
  article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
  contributor:
    fullname: Jemal
– volume: 53
  start-page: 293
  issue: 3
  year: 2013
  end-page: 297
  ident: CR7
  article-title: Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer
  publication-title: Aust N Z J Obstet Gynaecol
  doi: 10.1111/ajo.12089
  contributor:
    fullname: Kim
– start-page: 350
  year: 2000
  ident: CR19
  publication-title: Modeling survival data: extending the Cox model
  doi: 10.1007/978-1-4757-3294-8
  contributor:
    fullname: Grambsch
– volume: 35
  start-page: 115
  issue: 1
  year: 2011
  end-page: 126
  ident: CR25
  article-title: Histologic artifacts in abdominal, vaginal, laparoscopic, and robotic hysterectomy specimens: a blinded retrospective review
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e31820273dc
  contributor:
    fullname: Boerner
– volume: 47
  start-page: 355
  issue: 4
  year: 2013
  end-page: 364
  ident: CR14
  article-title: ERG Immunohistochemistry as an endothelial marker for assessing lymphovascular invasion
  publication-title: Korean J Pathol
  doi: 10.4132/KoreanJPathol.2013.47.4.355
  contributor:
    fullname: Kim
– volume: 27
  start-page: 1191
  issue: 6
  year: 2017
  end-page: 1199
  ident: CR20
  article-title: Lymphovascular space invasion for endometrial cancer: undertreatment and overtreatment risks
  publication-title: Int J Gynecol Cancer
  doi: 10.1097/IGC.0000000000001022
  contributor:
    fullname: Padilla
– ident: CR17
– volume: 245
  start-page: 181
  year: 2020
  end-page: 185
  ident: CR22
  article-title: Feasibility and perioperative outcomes of percutaneous-assisted laparoscopic hysterectomy: a multicentric Italian experience
  publication-title: Eur J Obstet Gynecol Reprod Biol
  doi: 10.1016/j.ejogrb.2019.12.020
  contributor:
    fullname: Fedele
– volume: 115
  start-page: 211
  issue: 2
  year: 2004
  end-page: 215
  ident: CR30
  article-title: Does fluid hysteroscopy increase the stage or worsen the prognosis in patients with endometrial cancer? A randomized controlled trial
  publication-title: Eur J Obstet Gynecol Reprod Biol
  doi: 10.1016/j.ejogrb.2004.01.029
  contributor:
    fullname: Rivas
– volume: 31
  start-page: 12
  issue: 1
  year: 2021
  end-page: 39
  ident: CR4
  article-title: ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2020-002230
  contributor:
    fullname: Marnitz
– volume: 140
  start-page: 387
  issue: 3
  year: 2016
  end-page: 393
  ident: CR6
  article-title: Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2016.01.002
  contributor:
    fullname: Hu
– volume: 371
  start-page: 569
  issue: 9612
  year: 2008
  end-page: 578
  ident: CR3
  article-title: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)60269-X
  contributor:
    fullname: Zwahlen
– year: 2016
  ident: CR13
  publication-title: Fundamental texts on European private law
  doi: 10.5040/9781782258674
  contributor:
    fullname: Zimmermann
– volume: 72
  start-page: 1247
  issue: 4
  year: 2020
  end-page: 1254
  ident: CR24
  article-title: Uterine manipulator in total laparoscopic hysterectomy: safety and usefulness
  publication-title: Updat Surg
  doi: 10.1007/s13304-019-00681-w
  contributor:
    fullname: Biondi
– volume: 96
  start-page: 957
  issue: 4
  year: 2011
  end-page: 961.e2
  ident: CR34
  article-title: Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2011.07.1146
  contributor:
    fullname: Duan
– volume: 38
  start-page: S114
  year: 2019
  end-page: S122
  ident: CR5
  article-title: International society of gynecological pathologists (ISGyP) endometrial cancer project: guidelines from the special techniques and ancillary studies group
  publication-title: Int J Gynecol Pathol
  doi: 10.1097/PGP.0000000000000496
  contributor:
    fullname: Howitt
– volume: 140
  start-page: 387
  issue: 3
  year: 2016
  ident: 3310_CR6
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2016.01.002
  contributor:
    fullname: S Jorge
– volume: 23
  start-page: e2019.00021
  issue: 2
  year: 2019
  ident: 3310_CR28
  publication-title: JSLS
  doi: 10.4293/JSLS.2019.00021
  contributor:
    fullname: F Seifi
– volume: 27
  start-page: 1191
  issue: 6
  year: 2017
  ident: 3310_CR20
  publication-title: Int J Gynecol Cancer
  doi: 10.1097/IGC.0000000000001022
  contributor:
    fullname: M Gorostidi Pulgar
– volume: 9
  start-page: 7759
  issue: 12
  year: 2020
  ident: 3310_CR21
  publication-title: Transl Cancer Res
  doi: 10.21037/tcr-20-2094
  contributor:
    fullname: VA Capozzi
– volume: 96
  start-page: 957
  issue: 4
  year: 2011
  ident: 3310_CR34
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2011.07.1146
  contributor:
    fullname: YN Chang
– volume: 105
  start-page: 103
  issue: 2
  year: 2009
  ident: 3310_CR15
  publication-title: Int J Gynaecol Obstet
  doi: 10.1016/j.ijgo.2009.02.012
  contributor:
    fullname: S Pecorelli
– volume: 243
  start-page: 120
  year: 2019
  ident: 3310_CR33
  publication-title: Eur J Obstet Gynecol Reprod Biol
  doi: 10.1016/j.ejogrb.2019.10.042
  contributor:
    fullname: A Namazov
– volume: 39
  start-page: 1
  issue: 5
  year: 2011
  ident: 3310_CR18
  publication-title: J Stat Softw
  doi: 10.18637/jss.v039.i05
  contributor:
    fullname: N Simon
– volume: 224
  start-page: 65.e1
  issue: 1
  year: 2021
  ident: 3310_CR9
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2020.07.025
  contributor:
    fullname: P Padilla-Iserte
– start-page: 350
  volume-title: Modeling survival data: extending the Cox model
  year: 2000
  ident: 3310_CR19
  doi: 10.1007/978-1-4757-3294-8
  contributor:
    fullname: TM Therneau
– year: 2022
  ident: 3310_CR31
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2022-003586
  contributor:
    fullname: R Quintana-Bertó
– volume: 35
  start-page: 7
  issue: 1
  year: 2014
  ident: 3310_CR12
  publication-title: Eur J Gynaecol Oncol
  contributor:
    fullname: SB Dewdney
– volume: 33
  start-page: 1
  issue: 1
  year: 2010
  ident: 3310_CR16
  publication-title: J Stat Softw
  doi: 10.18637/jss.v033.i01
  contributor:
    fullname: J Friedman
– ident: 3310_CR17
– volume: 105
  start-page: 110
  issue: 2
  year: 2009
  ident: 3310_CR29
  publication-title: Int J Gynecol Obstet
  doi: 10.1016/j.ijgo.2009.02.008
  contributor:
    fullname: A Mariani
– volume: 292
  start-page: 1003
  issue: 5
  year: 2015
  ident: 3310_CR23
  publication-title: Arch Gynecol Obstet
  doi: 10.1007/s00404-015-3727-9
  contributor:
    fullname: L van den Haak
– volume: 28
  start-page: 208
  issue: 2
  year: 2018
  ident: 3310_CR27
  publication-title: Int J Gynecol Cancer
  doi: 10.1097/IGC.0000000000001181
  contributor:
    fullname: H Machida
– volume: 115
  start-page: 211
  issue: 2
  year: 2004
  ident: 3310_CR30
  publication-title: Eur J Obstet Gynecol Reprod Biol
  doi: 10.1016/j.ejogrb.2004.01.029
  contributor:
    fullname: R Sáinz de la Cuesta
– volume: 32
  start-page: 560
  issue: 4
  year: 2008
  ident: 3310_CR10
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e31816098f0
  contributor:
    fullname: S Logani
– volume: 47
  start-page: 355
  issue: 4
  year: 2013
  ident: 3310_CR14
  publication-title: Korean J Pathol
  doi: 10.4132/KoreanJPathol.2013.47.4.355
  contributor:
    fullname: S Kim
– volume: 51
  start-page: 1742
  issue: 13
  year: 2015
  ident: 3310_CR8
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2015.05.015
  contributor:
    fullname: T Bosse
– volume: 33
  start-page: 298
  issue: 2
  year: 2009
  ident: 3310_CR26
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e31818a01bf
  contributor:
    fullname: S Kitahara
– volume: 35
  start-page: 115
  issue: 1
  year: 2011
  ident: 3310_CR25
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e31820273dc
  contributor:
    fullname: A Krizova
– volume: 71
  start-page: 209
  issue: 3
  year: 2021
  ident: 3310_CR2
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
  contributor:
    fullname: H Sung
– volume: 17
  start-page: 511
  issue: 3
  year: 2010
  ident: 3310_CR32
  publication-title: Menopause N Y N
  doi: 10.1097/gme.0b013e3181c8534d
  contributor:
    fullname: E Cicinelli
– volume: 371
  start-page: 569
  issue: 9612
  year: 2008
  ident: 3310_CR3
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)60269-X
  contributor:
    fullname: AG Renehan
– volume: 31
  start-page: 12
  issue: 1
  year: 2021
  ident: 3310_CR4
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2020-002230
  contributor:
    fullname: N Concin
– volume: 38
  start-page: S114
  year: 2019
  ident: 3310_CR5
  publication-title: Int J Gynecol Pathol
  doi: 10.1097/PGP.0000000000000496
  contributor:
    fullname: KR Cho
– volume: 73
  start-page: 17
  issue: 1
  year: 2023
  ident: 3310_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21763
  contributor:
    fullname: RL Siegel
– volume-title: Fundamental texts on European private law
  year: 2016
  ident: 3310_CR13
  doi: 10.5040/9781782258674
  contributor:
    fullname: O Radley-Gardner
– volume: 72
  start-page: 1247
  issue: 4
  year: 2020
  ident: 3310_CR24
  publication-title: Updat Surg
  doi: 10.1007/s13304-019-00681-w
  contributor:
    fullname: Y Abdel Khalek
– volume: 53
  start-page: 293
  issue: 3
  year: 2013
  ident: 3310_CR7
  publication-title: Aust N Z J Obstet Gynaecol
  doi: 10.1111/ajo.12089
  contributor:
    fullname: HS Hahn
– volume: 107
  start-page: 94
  issue: 1
  year: 2007
  ident: 3310_CR11
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2007.05.031
  contributor:
    fullname: I Takac
– volume: 245
  start-page: 181
  year: 2020
  ident: 3310_CR22
  publication-title: Eur J Obstet Gynecol Reprod Biol
  doi: 10.1016/j.ejogrb.2019.12.020
  contributor:
    fullname: S Gueli Alletti
SSID ssj0055611
Score 2.381911
Snippet Purpose The main goal of this study is to assess the impact of tumor manipulation on the presence of lympho-vascular space invasion and its influence on...
The main goal of this study is to assess the impact of tumor manipulation on the presence of lympho-vascular space invasion and its influence on oncological...
SourceID proquest
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 1098
SubjectTerms Medicine
Medicine & Public Health
Oncology
Research Article
Title Endometrial cancer: predictors and oncological safety of tumor tissue manipulation
URI https://link.springer.com/article/10.1007/s12094-023-03310-6
https://www.ncbi.nlm.nih.gov/pubmed/37668932
https://www.proquest.com/docview/2861304666
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT8MwDLZgkxAX3o_xmILEDTK1SZa13Da0MYHYAW3SOEVtkl7Q2mlrD_DrSfpgQkNIO_el2o79WbY_A9xGodTSURLrtmaYcUpx6HUoZpqZeKoJ8VTeIDviwwl7nranqznuvNm9qkjmjno160Ycy2JLKHaowSSYb0O9HDytd5_eX_qVA7YLH91yPubvJ3_HoDVguVYUzWPNYB_G1cRO0WLy0crSsCW_1gkcN_mNA9grsSfqFsZyCFs6PoKd17K6fgxv_VglM50v8kDSmsPiAc0X9rrdyYOCWKEklpW7RMsg0uknSiKUZrNkgdJcicgyalRbwU5gMuiPH4e43LmAJfG9FHcin7KAuLQTsUgyS5bKO7zNNGdSSRk5AfMty1vIPOlJ5QehIk5I2zbtsSyQ9BRqcRLrc0DMV1FoAJnrUMWUyexYwF3taBpIpYzfaMBdpQUxL6g1xIpE2YpJGDGJXEyCN-CmUpQwJ8CWNYJYJ9lSEM_mQMzkYQ04KzT48z7jPrlBZKQB95U6RHlIl_987GKz2y9hlxisU_RBXkEtXWT62mCVNGwa2xz0eqNmaaNN2J6Q7jfOoeGx
link.rule.ids 315,783,787,27936,27937,41093,41535,42162,42604,52123,52246
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3PS8MwFH7oBPUi_rb-jOBNA22Spq23IRtTtx1kg91Cm6S3taPtDv73Jl3rkInguW0KX5L3vsd773sAD2kitXSVxNrXDDNOKU7CgGKmmfGnmpBQ1QWyYz6YsreZP2uawsq22r1NSdaWet3sRlwrY0sodqkhJZhvw47VV7eK-VPSbe2vnffoNe0xv3_30wVt8MqNnGjtavqHcNBwRNRdbeoRbOnsGHZHTRb8BD56mcrnuh64gaTdtuIZLQr73M7OQXGmUJ7J1qyhMk519YnyFFXLeV6gqgYbWeWLdnrXKUz7vcnLADezEbAkUVjhII0oi4lHg5SlkllRUx5wn2nOpJIydWMWWTW2hIUylCqKE0XchPo2PLFqjfQMOlme6QtALFJpYoiT51LFlInAWMw97WoaS6XM_XbgsYVLLFYSGGItdmzBFQZcUYMruAP3LaLCnFSbfogznS9LQUIbqzATLzlwvoL6ez1j5rhhTsSBpxZ70Vym8o-fXf7v9TvYG0xGQzF8Hb9fwT4x_GRVu3gNnapY6hvDL6rktj5OX6BlxjY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB6VRIq4tJRHmxbKInGDbZzdycburSoJhUCEEJHKabXex6WKHSXOof313fWjAVpVQj3bXtszs7PfaGa-AXjvUm11ZDS1A4sUBec0jYecokV_nlrGYlMWyE7F-Qy_Xgwu_ujiL6vdm5Rk1dMQWJqyorcwrrdpfGNRoLRlnEbcAxQqnkAbAzNSC9qnn39PRo03DtMf-3WzzP1P_n0g3UGZdzKk5cEz3gHVfHJVb3J5vC7SY339D5vjY_7pGWzXqJScVma0C1s2ew6d73Xe_QX8HGUmn9tyxAfRwVCWJ2SxDNfDtB6iMkPyTDeOlKyUs8UVyR0p1vN8SYpSvSRwbTTzwl7CbDz6dXZO62kMVLMkLujQJRwV6_OhQ6cx0KiKoRigFaiN1i5SmAT-txRjHWuTqNSwKOWDEBAFfkj-ClpZntl9IJgYl3qo1o-4QeNjPlSibyPLlTbGe5QufGhUIhcV6Ybc0CsHMUkvJlmKSYouvGu0Jv3eCAkPldl8vZIsDtER-gitC3uVOm_X845VeKzGuvCxUY2st-_qgZcd_N_tb6Hz49NYfvsynRzCU-YBUVUs-RpaxXJt33hAU6RHtc3eAFz07AQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endometrial+cancer%3A+predictors+and+oncological+safety+of+tumor+tissue+manipulation&rft.jtitle=Clinical+%26+translational+oncology&rft.au=Quintana-Bert%C3%B3%2C+Raquel&rft.au=Padilla-Iserte%2C+Pablo&rft.au=Lago%2C+V%C3%ADctor&rft.au=Tauste%2C+Carmen&rft.date=2024-05-01&rft.issn=1699-3055&rft.eissn=1699-3055&rft.volume=26&rft.issue=5&rft.spage=1098&rft_id=info:doi/10.1007%2Fs12094-023-03310-6&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1699-3055&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1699-3055&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1699-3055&client=summon